Das M, Mukhtar H, DelTito B J, Marcelo C L, Bickers D R
J Invest Dermatol. 1986 Jul;87(1):4-10. doi: 10.1111/1523-1747.ep12523369.
The effect of the antifungal imidazole compound, clotrimazole, on the metabolism of benzo[a]pyrene (BP) was studied in cultured keratinocytes prepared from BALB/c mouse epidermis. Varying concentrations of clotrimazole added to the cultured keratinocytes resulted in a dose-dependent inhibition of the activities of the microsomal cytochrome P-450-dependent monooxygenases aryl hydrocarbon hydroxylase and 7-ethoxycoumarin O-deethylase. The major organic solvent-soluble metabolites of BP identified in the cultured cells were trans-7,8-dihydro-7,8-dihydroxybenzo[a]pyrene (BP-7,8-diol), 9-hydroxybenzo[a]pyrene (9-OH-BP), and 3-hydroxybenzo[a]pyrene (3-OH-BP), although small amounts of trans-4,5-dihydro-4,5-dihydroxybenzo[a]pyrene, BP-quinones, and trans-9,10-dihydroxybenzo[a]pyrene were also present. The major organic solvent-extractable metabolites of BP found in the extracellular culture medium were primarily the diols with smaller quantities of phenols and quinones. The major water-soluble metabolites of BP present both intracellularly and extracellularly were glucuronide conjugates of 3-OH-BP, 9-OH-BP, and benzo[a]pyrene-3,6-dione and to a lesser extent sulfate conjugates (primarily of the BP-7,8-diol). Clotrimazole inhibited the generation of organic solvent-soluble and water-soluble conjugates in a dose-dependent manner. The in vitro metabolism of BP by microsomes prepared from control and benz[a]anthracene (BA)-induced cultured keratinocytes was also inhibited by clotrimazole with greater inhibitory effect on BA-induced keratinocytes especially with respect to the formation of diols and quinones. The enzyme-mediated covalent binding of BP to mouse keratinocyte DNA and protein was also substantially diminished by clotrimazole in a dose-dependent fashion. These results indicate that clotrimazole, a widely used drug for the management of a variety of superficial dermatophyte infections of the skin, is a potent inhibitor of cytochrome P-450-dependent transformation of polycyclic aromatic hydrocarbons in cultured murine keratinocytes. This system offers a convenient approach for studies as inhibitors of carcinogen metabolism in the epidermis.
在从BALB/c小鼠表皮制备的培养角质形成细胞中,研究了抗真菌咪唑化合物克霉唑对苯并[a]芘(BP)代谢的影响。向培养的角质形成细胞中添加不同浓度的克霉唑会导致微粒体细胞色素P-450依赖性单加氧酶芳烃羟化酶和7-乙氧基香豆素O-脱乙基酶的活性受到剂量依赖性抑制。在培养细胞中鉴定出的BP主要有机溶剂可溶性代谢产物为反式-7,8-二氢-7,8-二羟基苯并[a]芘(BP-7,8-二醇)、9-羟基苯并[a]芘(9-OH-BP)和3-羟基苯并[a]芘(3-OH-BP),不过也存在少量的反式-4,5-二氢-4,5-二羟基苯并[a]芘、BP-醌和反式-9,10-二羟基苯并[a]芘。在细胞外培养基中发现的BP主要有机溶剂可提取代谢产物主要是二醇,酚类和醌类的量较少。细胞内和细胞外存在的BP主要水溶性代谢产物是3-OH-BP、9-OH-BP和苯并[a]芘-3,6-二酮的葡萄糖醛酸共轭物,以及程度较轻的硫酸盐共轭物(主要是BP-7,8-二醇的硫酸盐共轭物)。克霉唑以剂量依赖性方式抑制有机溶剂可溶性和水溶性共轭物的生成。从对照和苯并[a]蒽(BA)诱导的培养角质形成细胞制备的微粒体对BP的体外代谢也受到克霉唑的抑制,对BA诱导的角质形成细胞的抑制作用更大,尤其是对二醇和醌类的形成。克霉唑还以剂量依赖性方式显著减少了BP与小鼠角质形成细胞DNA和蛋白质的酶介导共价结合。这些结果表明克霉唑是一种广泛用于治疗各种皮肤浅表皮肤癣菌感染的药物,是培养的小鼠角质形成细胞中细胞色素P-450依赖性多环芳烃转化的有效抑制剂。该系统为研究表皮中致癌物代谢的抑制剂提供了一种便捷的方法。